Abstract:The majority of human skeleton develops through the endochondral pathway, in which cartilage-forming chondrocytes proliferate and enlarge into hypertrophic chondrocytes that eventually undergo apoptosis and are replaced by bone. Although at a terminal differentiation stage, hypertrophic chondrocytes have been implicated as the principal engine of bone growth. Abnormal chondrocyte hypertrophy has been seen in many skeletal dysplasia and osteoarthritis. Meanwhile, as a specific marker of hypertrophic chondrocytes, the type X collagen gene (COL10A1) is also critical for endochondral bone formation, as mutation and altered COL10A1 expression are often accompanied by abnormal chondrocyte hypertrophy in many skeletal diseases. However, how the type X collagen gene is regulated during chondrocyte hypertrophy has not been fully elucidated. We have recently demonstrated that Runx2 interaction with a 150-bp mouse Col10a1 cis-enhancer is required but not sufficient for its hypertrophic chondrocyte-specific reporter expression in transgenic mice, suggesting requirement of additional Col10a1 regulators. In this study, we report in silico sequence analysis of this 150-bp enhancer and identification of its multiple binding factors, including AP1, MEF2, NFAT, Runx1 and TBX5. Using this enhancer as bait, we performed yeast one-hybrid assay and identified multiple candidate Col10a1-interacting genes, including cyclooxygenase 1 (Cox-1) and Cox-2. We have also performed mass spectrometry analysis and detected EF1-alpha, Fus, GdF7 and Runx3 as components of the specific complex formed by the cis-enhancer and nuclear extracts from hypertrophic MCT (mouse chondrocytes immortalized with large T antigen) cells that express Col10a1 abundantly. Notably, some of the candidate genes are differentially expressed in hypertrophic MCT cells and have been associated with chondrocyte hypertrophy and Runx2, an indispensible Col10a1 regulator. Intriguingly, we detected high-level Cox-2 expression in hypertrophic MCT cells. Electrophoretic mobility shift assay and chromatin immunoprecipitation assays confirmed the interaction between Cox-2 and Col10a1 cis-enhancer, supporting its role as a candidate Col10a1 regulator. Together, our data support a Cox-2-containing, Runx2-centered Col10a1 regulatory mechanism, during chondrocyte hypertrophic differentiation.

Transgenic Mice That Express Cre Recombinasein Hypertrophic Chondrocytes

Generation of a Transgenic Mouse Model with Chondrocyte-Specific and Tamoxifen-Inducible Expression of Cre Recombinase.

Generation and Characterization of Chondrocyte Specific Cre Transgenic Mice

A highly conserved enhancer in mammalian type X collagen genes drives high levels of tissue-specific expression in hypertrophic cartilage in vitro and in vivo

Identification and characterization of the novel Col10a1 regulatory mechanism during chondrocyte hypertrophic differentiation

Expression Profiling and Functional Analysis of Candidate Col10a1 Regulators Identified by the TRAP Program

Conditional gene targeting in mouse high endothelial venules

Modeling of Transgenic Mice Cardiac- Specifically Overexpressing Human KCNE4 Gene

Expression of Cre Recombinase in an Enhancer-Cre Transgenic Mouse

Direct Reprogramming of Mouse Subchondral Bone Osteoblasts into Chondrocyte-like Cells

The generation and characterization of novel Col1a1FRT-Cre-ER-T2-FRT and Col1a1FRT-STOP-FRT-Cre-ER-T2 mice for sequential mutagenesis

Inner hair cell Cre-expressing transgenic mouse.

Transgenic mice with hematopoietic and lymphoid specific expression of Cre

Transgenic mice for cre-inducible overexpression of the Cul4A gene.

An Hsp70 promoter–based mouse for heat shock–induced gene modulation

Sites of Cre‐recombinase activity in mouse lines targeting skeletal cells

Generating Endogenous Myh11-driven Cre Mice for Sex-Independent Gene Deletion in Smooth Muscle Cells

A GCaMP reporter mouse with chondrocyte specific expression of a green fluorescent calcium indicator

Directed Expression of Cre in Alveolar Epithelial Type 1 Cells

Chondrocytes Transdifferentiate into Osteoblasts in Endochondral Bone during Development, Postnatal Growth and Fracture Healing in Mice

Generation of a novel constitutive smooth muscle cell-specific Myh11-driven Cre mouse model